Introduction
============

Visceral leishmanisis (VL) is a protozoal disease manifested as prolonged fever, hepatospleenomegaly, anorexia, and weight loss. It shows a spectrum of epidemiological diversity: *Leishmania donovani* is the causative agent of kala-azar in East Africa and Indian subcontinent, whereas *L. infantum* is found in Latin America and the Mediterranean basin ( [@B2]). Timely and accurate diagnosis of the condition is needed for proper treatment. Direct detection of amastigote forms in splenic or bone marrow aspirate is taken as the gold standard for diagnosis of VL, but these methods are invasive, carry high degree of risk for the patient and require technical expertise to detect. Recently, rk39 dip stick test has gained popularity because of high sensitivity, specificity, rapidity, and easy to use ( [@B5]). This can be used as field test for diagnosis of VL cases in kala-azar endemic areas ( [@B1]). But, the major limitation of the test is false positive result in cured patients due to persistence of antibody. Urine and sputum samples from kala-azar patients proved as useful as serum for the diagnosis of VL by variety of diagnostic tests ( [@B6]). However, the role of saliva is not established in the diagnosis of VL patients.

In this study, we compared serum, urine, and saliva samples of clinically diagnosed VL cases by rk39 dip stick test for the diagnosis of VL and also followed up to evaluate their utility in the prognosis of patients.

Materials and Methods
=====================

As per WHO, a VL case is defined as a person from an endemic region with fever for more than 2 weeks, spleenomegaly and confirmed positive by either rapid diagnostic test based on rk39 antigen or biopsy ( [@B3]).

A total of 72 clinically suspected VL patients were enrolled in the study from 2011 to 2012 within a period of 2 year. Ethical clearance for the study was not required as the samples were referred to the Microbiology Laboratory for the diagnostic purposes as a public health measure. Sixty one out of these 72 patients were diagnosed as VL as per the above definition and included in the test group. Rest 11 cases were included in the control group (n= 11), which consisted of pyrexia of unknown origin (PUO) (n= 1), post kala-azar dermal leishmaniasis (PKDL) (n= 3), past history of kala-azar (n= 2), mycosis fungoidosis (n= 1), malaria (n= 3), and filaria (n= 2). Serum, urine and saliva samples were collected from all patients (cases and controls) and tested for rk39dip stick test. Detailed clinical history of the patients such as fever, hepatospleenomegaly, residence, weight loss, loss of appetite, complete blood count, albumin: globulin ratio, liver function test, and past history of kala-azar were obtained from all patients.

Serum sample was tested for rk39 test (Kalaazar Detect^TM^ Rapid Test, InBios International, USA) as per the instruction of the kit. Urine and saliva samples were tested with rk39 strip test following the similar procedure. Only 11 patients out of 61 VL confirmed cases in the test group could be followed up to 3--4 months after completion of treatment and rk39 test with serum, urine and saliva samples were repeated. All the rk39 test strips were graded from 3+ (equal to or more than control) to 1+ (faint) depending on the intensity of test band in comparison with control band. Statistical analysis could not be done because of small sample size.

Results
=======

All patients in the test group (n= 61) presented with fever for more than 2 weeks and hepatospleenomegaly during the first visit to the hospital. On examination, features like pancytopenia, anorexia, weight loss, hypoproteinemia, and reversal of albumin: globulin ratio was observed less frequently in comparison to the previous one.

Rk39 dip stick test with serum sample was positive in all the patients (100%) of test group ([Table 1](#T1){ref-type="table"}). Urine showed a complete concordance with serum exhibiting 100 % positivity in all the patients of the test group, whereas only 51 patients (83.6%) were found positive with saliva sample. Eleven patients from the test group were followed up after the completion of treatment and tested with serum, urine and saliva samples to observe the response of treatment. All the cases in the follow up group showed positive result with serum and urine samples in comparison to 10 cases with saliva.

###### 

Comparison of rk39 test with serum, urine, and saliva samples in kalaazar patients and the control group

                              **Kalaazar pts. (n= 61)**   **F/up cases (n= 11)**   **Control (n= 11)**
  --------------------------- --------------------------- ------------------------ ---------------------
  **Serum Positive n (%)**    61 (100)                    11(100)                  4(37)
  **Urine Positive n (%)**    61 (100)                    11(100)                  2(18)
  **Saliva Positive n (%)**   51 (83.6)                   10(91)                   1(9)

We graded the intensity of the test band of the rk39 strip of these 11 patients before and after treatment as it indirectly correlates the disease status ([Table 2](#T2){ref-type="table"}). The test band intensity with serum sample before and after therapy obtained to be same among these patients. The band intensity found to be reduced with the urine and saliva samples in 4 cases after completion of therapy ([Table 2](#T2){ref-type="table"}). Among the control patients (n= 11), the rk39 test with serum, urine and saliva sample found positive in 7 (63.6%), 2 (18%), and 1 (9%) case respectively ([Table 3](#T3){ref-type="table"}).

###### 

Gradation of test band intensity rk39 strips in the kalaazar patients before and after treatment

  **Pts. Sl. No.**   **Serum**   **Serum F/up**   **Urine**   **Urine F/up**   **Saliva**   **Saliva F/up**
  ------------------ ----------- ---------------- ----------- ---------------- ------------ -----------------
  **1.**             4+          4+               4+          4+               4+           4+
  **2.**             3+          1+               1+          1+               1+           1+
  **3.**             4+          4+               4+          2+               4+           2+
  **4.**             4+          3+               3+          1+               1+           negative
  **5.**             3+          4+               3+          4+               3+           3+
  **6.**             4+          4+               4+          1+               4+           2+
  **7.**             4+          4+               2+          2+               3+           1+
  **8.**             4+          4+               4+          4+               4+           4+
  **9.**             4+          4+               4+          2+               4+           4+
  **10.**            4+          4+               4+          4+               4+           3+
  **11.**            3+          2+               3+          3+               3+           1+

1+ and 2+: band intensity weaker than control, 3+: band intensity matches with control, 4+: band intensity stronger than control

###### 

Comparison of rk39 test with serum, urine, and saliva samples in control group

                                  **Serum**   **Urine**   **Saliva**
  ------------------------------- ----------- ----------- ------------
  **PKDL**                                                
  **1.**                          4+          Neg         Neg
  **2.**                          1+          Neg         Neg
  **3.**                          1+          Neg         Neg
  **Past H/O Kalaazar**                                   
  **1.**                          3+          Neg         Neg
  **2.**                          1+          1+          Neg
  **Pyrexia of Unknown Origin**   2+          Neg         Neg
  **Mycosis fungoidosis**         3+          2+          2+
  **Malaria**                                             
  **1.**                          Neg         Neg         Neg
  **2.**                          Neg         Neg         Neg
  **Filaria**                                             
  **1.**                          Neg         Neg         Neg
  **2.**                          Neg         Neg         Neg

Discussion
==========

This study was designed to detect the performance of non-invasive samples for the diagnosis and prognosis of VL patients.

It is known that the test band intensity of the ICT strip correlates with the course of many diseases ( [@B4], [@B7]). The intensity is maximum during the active phase of the disease and gradually fades after treatment. In our study, urine was more useful in comparison to saliva for the diagnosis of kala-azar in the active stage of disease. During the first visit, the result of rk39 test with urine sample showed complete concordance with that of the serum sample. However, saliva was positive in 84 % cases. The urine and saliva samples showed similar results as with serum samples in follow up patients. It shows that, urine and saliva do not have much role in the determination of prognosis of VL patients. But, in the control group, the rk39 test with the saliva sample was found negative in majority (10/11, 91%) of cases in comparison to serum (4/11, 36.4 %). The test was also observed to be negative in majority of cases with urine sample.

Conditions such as past history of kalaazar, post kala-azar dermal leishmaniasis showed false positive result with serum sample in the control group. All these conditions found to be negative with saliva. The sensitivity and specificity of rk39 test is reported differently in different literatures. Singh et al. found sputum samples to be highly specific for VL patients (2009). Many literatures discussed about the false positive result of urine sample for the diagnosis of VL ( [@B1]). But, in this study the false positive results by urine sample was much less.

The limitation of the study is that, it is comprised of less number of patients in the control group and also did not include the samples of healthy persons from endemic area. However, the results were encouraging. Non-invasive samples in endemic area can be used as an adjunct to the serum samples to decrease the rate of false positivity. Urine and saliva samples can also be used as part of surveillance in countries where animals behave as reservoir and help to control VL ( [@B8]). The role of non-invasive samples in the prognosis of the patients is also difficult to establish because of small sample size in the follow up group. To overcome these limitations and to determine their role, further studies in field with a large sample size is required.

Conclusion
==========

The present data highlights the usefulness of non-invasive samples such as urine and saliva as the diagnostic tools for the patients of kala-azar particularly in endemic regions. They were equally good with regard to as serum samples tested by rk39 strip. These samples can be collected easily in a non-invasive manner. Hence, rk39dip stick test with noninvasive samples such as urine and saliva may be adapted in routine diagnostics along with serum samples in endemic areas for the diagnosis of VL conditions. This may reduce the rate of false positivity with serum samples.
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